| CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence KC Kurnit, GN Kim, BM Fellman, DL Urbauer, GB Mills, W Zhang, ... Modern Pathology 30 (7), 1032-1041, 2017 | 244 | 2017 |
| Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study PA Parker, F Alba, B Fellman, DL Urbauer, Y Li, JA Karam, N Tannir, ... European urology 63 (6), 1122-1127, 2013 | 121 | 2013 |
| Survival in differentiated thyroid cancer: comparing the AJCC cancer staging seventh and eighth editions S Tam, M Boonsripitayanon, M Amit, BM Fellman, Y Li, NL Busaidy, ... Thyroid 28 (10), 1301-1310, 2018 | 112 | 2018 |
| Overall survival after pelvic exenteration for gynecologic malignancy SN Westin, V Rallapalli, B Fellman, DL Urbauer, N Pal, MM Frumovitz, ... Gynecologic oncology 134 (3), 546-551, 2014 | 111 | 2014 |
| Efficacy trial of an Internet-based intervention for cancer-related female sexual dysfunction LR Schover, Y Yuan, BM Fellman, E Odensky, PE Lewis, P Martinetti Journal of the National Comprehensive Cancer Network 11 (11), 1389-1397, 2013 | 110 | 2013 |
| Longitudinal outcomes of an institutionally developed nurse residency program D Cline, K La Frentz, B Fellman, B Summers, K Brassil JONA: The Journal of Nursing Administration 47 (7/8), 384-390, 2017 | 101 | 2017 |
| ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer KM Schmeler, R Pareja, AL Blanco, JH Fregnani, A Lopes, M Perrotta, ... International Journal of Gynecologic Cancer 31 (10), 2021 | 98 | 2021 |
| Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation F Kawakami, K Sircar, J Rodriguez‐Canales, BM Fellman, DL Urbauer, ... Cancer 123 (24), 4823-4831, 2017 | 95 | 2017 |
| Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients JR Galloway-Peña, DP Smith, P Sahasrabhojane, WD Wadsworth, ... Genome medicine 9, 1-14, 2017 | 95 | 2017 |
| Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome BAL Batte, AS Bruegl, MS Daniels, KL Ring, KM Dempsey, B Djordjevic, ... Gynecologic oncology 134 (2), 319-325, 2014 | 90 | 2014 |
| Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre C Zhou, DL Urbauer, BM Fellman, P Tamboli, M Zhang, SF Matin, ... BJU international 117 (5), 775-782, 2016 | 85 | 2016 |
| Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer SN Westin, B Fellman, CC Sun, RR Broaddus, ML Woodall, N Pal, ... American journal of obstetrics and gynecology 224 (2), 191. e1-191. e15, 2021 | 74 | 2021 |
| Everolimus, letrozole, and metformin in women with advanced or recurrent endometrioid endometrial cancer: a multi-center, single arm, phase II study PT Soliman, SN Westin, DA Iglesias, BM Fellman, Y Yuan, Q Zhang, ... Clinical Cancer Research 26 (3), 581-587, 2020 | 73 | 2020 |
| Priorities for oncology nursing research: the 2013 national survey. G LoBiondo-Wood, CG Brown, M Knobf, D Lyon, G Mallory, SA Mitchell, ... Oncology nursing forum 41 (1), 2014 | 59 | 2014 |
| Laparoscopic surgical algorithm to triage the timing of tumor reductive surgery in advanced ovarian cancer ND Fleming, AM Nick, RL Coleman, SN Westin, PT Ramirez, PT Soliman, ... Obstetrics & Gynecology 132 (3), 545-554, 2018 | 58 | 2018 |
| EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant … SN Westin, RL Coleman, BM Fellman, Y Yuan, AK Sood, PT Soliman, ... Journal of Clinical Oncology 39 (15_suppl), 5505-5505, 2021 | 56 | 2021 |
| Integrative oncology physician consultations at a comprehensive cancer center: analysis of demographic, clinical and patient reported outcomes G Lopez, J McQuade, L Cohen, JT Williams, AR Spelman, B Fellman, Y Li, ... Journal of Cancer 8 (3), 395, 2017 | 53 | 2017 |
| Attitudes toward molecular testing for personalized cancer therapy RA Yusuf, D Rogith, SRA Hovick, SK Peterson, AM Burton‐Chase, ... Cancer 121 (2), 243-250, 2015 | 53 | 2015 |
| Clinical challenges associated with universal screening for Lynch syndrome–associated endometrial cancer AS Bruegl, KL Ring, M Daniels, BM Fellman, DL Urbauer, RR Broaddus Cancer Prevention Research 10 (2), 108-115, 2017 | 52 | 2017 |
| Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery PA Parker, R Swartz, B Fellman, D Urbauer, Y Li, LL Pisters, CJ Rosser, ... The Journal of urology 187 (3), 822-826, 2012 | 51 | 2012 |
